Why is Zhuhai Rundu Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -1.74% and Operating profit at -187.01% over the last 5 years
2
The company declared very negative results in Mar'25 after flat results in Dec'24
- OPERATING CASH FLOW(Y) Lowest at CNY 91 MM
- NET PROFIT(Q) At CNY -18.5 MM has Fallen at -116.91%
- ROCE(HY) Lowest at -4.73%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 23.26%, its profits have fallen by -196.2%
- At the current price, the company has a high dividend yield of 0.9
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Zhuhai Rundu Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Zhuhai Rundu Pharmaceutical Co., Ltd.
20.09%
0.96
52.83%
China Shanghai Composite
15.17%
1.02
14.86%
Quality key factors
Factor
Value
Sales Growth (5y)
-1.74%
EBIT Growth (5y)
-187.01%
EBIT to Interest (avg)
34.30
Debt to EBITDA (avg)
1.60
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.70
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
125.94%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.84%
ROE (avg)
8.76%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.97
EV to EBIT
-92.65
EV to EBITDA
48.09
EV to Capital Employed
3.11
EV to Sales
4.18
PEG Ratio
NA
Dividend Yield
0.91%
ROCE (Latest)
-3.35%
ROE (Latest)
-3.20%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Movement
4What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -0.83% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 1.79 times
NET SALES(Q)
Highest at CNY 336.33 MM
-19What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CNY 91 MM
NET PROFIT(Q)
At CNY -18.5 MM has Fallen at -116.91%
ROCE(HY)
Lowest at -4.73%
DEBT-EQUITY RATIO
(HY)
Highest at 37.07 %
OPERATING PROFIT(Q)
Lowest at CNY -13.26 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -3.94 %
Here's what is working for Zhuhai Rundu Pharmaceutical Co., Ltd.
Net Sales
Highest at CNY 336.33 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Sales
At CNY 336.33 MM has Grown at 18.71%
over average net sales of the previous four periods of CNY 283.32 MMMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Inventory Turnover Ratio
Highest at 1.79 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -0.83% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Zhuhai Rundu Pharmaceutical Co., Ltd.
Net Profit
At CNY -18.5 MM has Fallen at -116.91%
over average net sales of the previous four periods of CNY -8.53 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Operating Cash Flow
Lowest at CNY 91 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Operating Profit
Lowest at CNY -13.26 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -3.94 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Debt-Equity Ratio
Highest at 37.07 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






